Infantile Spasms Therapeutics Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

    The worldwide Infantile Spasms Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

    This report presents the market size and development trends by detailing the Infantile Spasms Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Infantile Spasms Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Infantile Spasms Therapeutics industry and will help you to build a panoramic view of the industrial development.

    Infantile Spasms Therapeutics Market, By Type:

    • Oral

    • Injection

    Infantile Spasms Therapeutics Market, By Application:

    • Hospital

    • Clinic

    • Other

    Some of the leading players are as follows:

    • Catalyst Pharmaceuticals

    • Mallinckrodt

    • Anavex Life Sciences

    • Orphelia Pharma

    • Retrophin

    • Insys Therapeutics

    • Valerion Therapeutics

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Infantile Spasms Therapeutics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Oral

      • 1.3.2 Injection

    • 1.4 Market Segment by Application

      • 1.4.1 Hospital

      • 1.4.2 Clinic

      • 1.4.3 Other

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Infantile Spasms Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Infantile Spasms Therapeutics by Major Types

      • 3.4.1 Oral

      • 3.4.2 Injection

    4 Segmentation of Infantile Spasms Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Infantile Spasms Therapeutics by Major End-Users

      • 4.4.1 Hospital

      • 4.4.2 Clinic

      • 4.4.3 Other

    5 Market Analysis by Major Regions

    • 5.1 Global Infantile Spasms Therapeutics Production Analysis by Top Regions

    • 5.2 Global Infantile Spasms Therapeutics Consumption Analysis by Top Regions

    • 5.3 Global Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Infantile Spasms Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in Infantile Spasms Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Infantile Spasms Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Infantile Spasms Therapeutics Landscape Analysis

    • 7.1 North America Infantile Spasms Therapeutics Landscape Analysis by Top Countries

      • 7.1.1 United States Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 7.1.2 Canada Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 7.1.3 Mexico Infantile Spasms Therapeutics Market Volume and Growth Rate

    8. Europe Infantile Spasms Therapeutics Landscape Analysis

    • 8.1 Europe Infantile Spasms Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe Infantile Spasms Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe Infantile Spasms Therapeutics Landscape Analysis by Top Countries

      • 8.3.1 Germany Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.3 France Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.5 Spain Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.6 Belgium Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.7 Poland Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.8 Russia Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.9 Turkey Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.10 Netherlands Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.11 Portugal Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.12 Denmark Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.13 Finland Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.14 Iceland Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.15 Norway Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 8.3.16 Sweden Infantile Spasms Therapeutics Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Infantile Spasms Therapeutics Landscape Analysis

    • 9.1 Asia Pacific Infantile Spasms Therapeutics Landscape Analysis by Top Countries

      • 9.1.1 China Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 9.1.2 Japan Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 9.1.4 India Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 9.1.5 ASEAN Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 9.1.6 South Korea Infantile Spasms Therapeutics Market Volume and Growth Rate

    10 LAMEA Infantile Spasms Therapeutics Landscape Analysis

    • 10.1 LAMEA Infantile Spasms Therapeutics Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 10.1.2 Brazil Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 10.1.3 North Africa Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 10.1.4 South Africa Infantile Spasms Therapeutics Market Volume and Growth Rate

      • 10.1.5 Argentina Infantile Spasms Therapeutics Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Catalyst Pharmaceuticals

      • 11.1.1 Catalyst Pharmaceuticals Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Mallinckrodt

      • 11.2.1 Mallinckrodt Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Anavex Life Sciences

      • 11.3.1 Anavex Life Sciences Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Orphelia Pharma

      • 11.4.1 Orphelia Pharma Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Retrophin

      • 11.5.1 Retrophin Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Insys Therapeutics

      • 11.6.1 Insys Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Valerion Therapeutics

      • 11.7.1 Valerion Therapeutics Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 121 Figures and 165 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Injection

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Other

    • Figure North America Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure United States Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure China Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure India Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Infantile Spasms Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Infantile Spasms Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Infantile Spasms Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Infantile Spasms Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Infantile Spasms Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Injection

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Infantile Spasms Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Infantile Spasms Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Other

    • Table Global Infantile Spasms Therapeutics Production by Major Regions

    • Table Global Infantile Spasms Therapeutics Production Share by Major Regions

    • Table Global Infantile Spasms Therapeutics Consumption by Major Regions

    • Table Global Infantile Spasms Therapeutics Consumption Share by Major Regions

    • Table North America Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

    • Table LAMEA Infantile Spasms Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Infantile Spasms Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Infantile Spasms Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America Infantile Spasms Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Infantile Spasms Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America Infantile Spasms Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America Infantile Spasms Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe Infantile Spasms Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Infantile Spasms Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Infantile Spasms Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure China Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Infantile Spasms Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Infantile Spasms Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Infantile Spasms Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Catalyst Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Catalyst Pharmaceuticals

    • Table Product and Service Introduction of Catalyst Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anavex Life Sciences

    • Figure Sales and Growth Rate Analysis of Anavex Life Sciences

    • Figure Revenue and Market Share Analysis of Anavex Life Sciences

    • Table Product and Service Introduction of Anavex Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphelia Pharma

    • Figure Sales and Growth Rate Analysis of Orphelia Pharma

    • Figure Revenue and Market Share Analysis of Orphelia Pharma

    • Table Product and Service Introduction of Orphelia Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Retrophin

    • Figure Sales and Growth Rate Analysis of Retrophin

    • Figure Revenue and Market Share Analysis of Retrophin

    • Table Product and Service Introduction of Retrophin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insys Therapeutics

    • Figure Sales and Growth Rate Analysis of Insys Therapeutics

    • Figure Revenue and Market Share Analysis of Insys Therapeutics

    • Table Product and Service Introduction of Insys Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valerion Therapeutics

    • Figure Sales and Growth Rate Analysis of Valerion Therapeutics

    • Figure Revenue and Market Share Analysis of Valerion Therapeutics

    • Table Product and Service Introduction of Valerion Therapeutics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.